RapidX
5 minute point-of-care qPCR tests powered by nanotechnology
Point-of-care testing for bacteria and viruses with extremely short time-to-result (TTR) and multiplexing capabilities of up to 12 targets.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Research
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Co-develop
- License
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
We’re looking for clinical partners to access patient samples for trials, or PCR assay/AST genotyping partners to test their assays in our machines.
Our mission is to create 30 minute pathways from symptom to treatment
n/a
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!